Consequently, miR-486-5p is pivotal in the self-renewal of lung cancer stem cells via the p85/Akt signaling pathway, and the lipid nanoparticle delivery system offers a novel strategy for its clinical application, anticipated to serve as a potential target for lung cancer treatment [53]. The gene discussed is AKT1; the disease is lung carcinoma.